The cost-effectiveness of orphan drugs
- PMID: 1900676
- PMCID: PMC1405048
- DOI: 10.2105/ajph.81.4.414
The cost-effectiveness of orphan drugs
Comment on
-
Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.Am J Public Health. 1991 Apr;81(4):427-33. doi: 10.2105/ajph.81.4.427. Am J Public Health. 1991. PMID: 1900677 Free PMC article.
Similar articles
-
Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis.Chest. 2000 Mar;117(3):875-80. doi: 10.1378/chest.117.3.875. Chest. 2000. PMID: 10713018
-
Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.Am J Public Health. 1991 Apr;81(4):427-33. doi: 10.2105/ajph.81.4.427. Am J Public Health. 1991. PMID: 1900677 Free PMC article.
-
Clinical trials to treat the underlying cause of emphysema.Monaldi Arch Chest Dis. 1994 Apr;49(2):95-7. Monaldi Arch Chest Dis. 1994. PMID: 8049708 No abstract available.
-
Lung transplantation for alpha 1-antitrypsin deficiency emphysema.Chest. 1996 Dec;110(6 Suppl):284S-294S. doi: 10.1378/chest.110.6_supplement.284s. Chest. 1996. PMID: 8989166 Review.
-
[Genetics of alpha 1-antitrypsin and chronic obstructive lung diseases].Ter Arkh. 1977;49(10):132-8. Ter Arkh. 1977. PMID: 339390 Review. Russian. No abstract available.
Cited by
-
Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.Paediatr Drugs. 2008;10(3):193-7. doi: 10.2165/00148581-200810030-00007. Paediatr Drugs. 2008. PMID: 18454571
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources